Amwins, an independent wholesale distributor of specialty insurance products, has launched its first comprehensive and proprietary portfolio of data and analytics capabilities, Amwins DNA.
According to the firm, Amwins DNA’s capabilities can help the company to ensure that it finds the best solutions for its clients and their insureds, as well as understand the risk appetite of their market partners for better placement decisions.
In addition, Amwins DNA can also help the firm to successfully build capacity and create new and exclusive products and programs.
As well as this, it can also help the firm to provide client deliverables, and efficiently identify expertise within the company regarding tough classes of business to match market underwriting appetites within the Amwins platform.
Scott Purviance, Amwins chief executive officer, commented: “We call these capabilities Amwins DNA because data and analytics are part of who we are, part of our makeup as a firm. Many components have been in place since our earliest days, and we’ve made recent investments to further enhance our data and analytics capabilities to provide tools for our Amwins colleagues to use in delivering unparalleled service to our clients.”
He continued: “Data and analytics are increasingly enhancing the way we serve our clients, but Amwins team members truly are the difference makers that drive our firm’s success. Amwins DNA exists to support our colleagues and their specialized product knowledge and to supplement their ability to execute for their clients. We encourage clients to give their Amwins broker a call to explore our Amwins DNA capabilities and see for themselves how these tools help them win.”
Chris Gill, Amwins executive vice president, said: “By establishing the Amwins DNA brand, we intend to demonstrate our continued commitment to bring all our resources together to help our clients and market partners capitalize on the advantages that come from partnering with Amwins.”
